Search Results - sadia+noosrat+boshra

1 Results Sort By:
Stavudine as a Potential Anticancer Agent for the Treatment of Pancreatic Cancer
Advantages: Repurposes an existing FDA-approved drug Achieves dose-dependent inhibition of ASPC-1 pancreatic cancer cell proliferation May enhance treatment efficacy when combined with standard chemotherapy Summary: Pancreatic cancer remains one of the most lethal malignancies due to late diagnosis, limited treatment efficacy, and a tumor microenvironment...
Published: 3/10/2025   |   Inventor(s): Sadia Noosrat Boshra, Mildred Acevedo-Duncan, Kirpal Bisht
Keywords(s): Cancer Treatment Pancreatic Cancer
Category(s): Technology Classifications > Cancer > Cancer Treatment Adenocarcinomas, Technology Classifications > Medical > Oncology